eValuating iDA Selection Ability. The VISA Study.

  • STATUS
    Recruiting
  • End date
    Mar 31, 2022
  • participants needed
    1040
  • sponsor
    Vitrolife
Updated on 31 July 2021
ovarian stimulation
embryo culture

Summary

A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in an equally as high clinical pregnancy rate compared to trained embryologists using standard morphology criteria.

Details
Condition assisted reproductive technology, Female Genital Diseases, Infertility, In Vitro Fertilization, assisted reproductive technologies, sterility, unable to conceive
Treatment iDAScore®
Clinical Study IdentifierNCT04969822
SponsorVitrolife
Last Modified on31 July 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Women undergoing IVF or ICSI with controlled ovarian stimulation with gonadotrophins and the intention to treat by either transfer of a single fresh embryo on day 5 or in case of a freeze all cycle, the first rewarmed embryo
Age: Up to and including the 42nd completed birthday on the day of randomization
Has at least two early blastocysts on day 5

Exclusion Criteria

Treatment involving donated eggs
Intention to perform any form of preimplantation genetic testing
The use of IMSI or polarized light in the ICSI process
The use of assisted hatching prior to randomization
Previous participation in this RCT
Where the cycle is carried out for fertility preservation
If a day 2-4 transfer is planned
Has a reduced likelihood of obtaining two early blastocysts on day 5 as evidenced by either: an AMH level of <3pmol/L or AFC <5 (if available)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note